Vianet Group plc (AIM:VNET)
London · Delayed Price · Currency is GBP · Price in GBX 83.50
+0.50 (0.60%)
Aug 8, 2025, 4:35 PM GMT+1
Regulus Therapeutics Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 15.02 | 14.92 | 14.12 | 13.22 | 8.37 | Upgrade | |
Revenue Growth (YoY) | 0.72% | 5.67% | 6.81% | 57.90% | -48.60% | Upgrade |
Cost of Revenue | 4.6 | 4.49 | 4.74 | 4.65 | 3.31 | Upgrade |
Gross Profit | 10.42 | 10.43 | 9.38 | 8.56 | 5.06 | Upgrade |
Selling, General & Admin | 6.83 | 6.96 | 6.27 | 6.2 | 5.85 | Upgrade |
Other Operating Expenses | -0.25 | - | - | - | - | Upgrade |
Operating Expenses | 8.95 | 9.23 | 8.6 | 8.48 | 7.59 | Upgrade |
Operating Income | 1.47 | 1.21 | 0.78 | 0.09 | -2.53 | Upgrade |
Interest Expense | -0.4 | -0.32 | -0.24 | -0.14 | -0.05 | Upgrade |
Interest & Investment Income | 0.06 | 0.05 | 0.03 | - | 0 | Upgrade |
EBT Excluding Unusual Items | 1.12 | 0.93 | 0.57 | -0.05 | -2.58 | Upgrade |
Merger & Restructuring Charges | -0.18 | -0.41 | -0.08 | -0.19 | -0.15 | Upgrade |
Other Unusual Items | -0.01 | 0.27 | -0.04 | 0.07 | -0.09 | Upgrade |
Pretax Income | 0.93 | 0.78 | 0.45 | -0.17 | -2.82 | Upgrade |
Income Tax Expense | 0.07 | 0.25 | 0.29 | -0.36 | -0.87 | Upgrade |
Earnings From Continuing Operations | 0.86 | 0.54 | 0.16 | 0.19 | -1.96 | Upgrade |
Net Income | 0.86 | 0.54 | 0.16 | 0.19 | -1.96 | Upgrade |
Net Income to Common | 0.86 | 0.54 | 0.16 | 0.19 | -1.96 | Upgrade |
Net Income Growth | 60.19% | 232.30% | -13.90% | - | - | Upgrade |
Shares Outstanding (Basic) | 29 | 29 | 29 | 29 | 29 | Upgrade |
Shares Outstanding (Diluted) | 30 | 30 | 29 | 30 | 29 | Upgrade |
Shares Change (YoY) | 0.61% | 3.01% | -2.62% | 2.42% | 0.91% | Upgrade |
EPS (Basic) | 0.03 | 0.02 | 0.01 | 0.01 | -0.07 | Upgrade |
EPS (Diluted) | 0.03 | 0.02 | 0.01 | 0.01 | -0.07 | Upgrade |
EPS Growth | 58.90% | 222.10% | -11.29% | - | - | Upgrade |
Free Cash Flow | 3.99 | 4.02 | 1.39 | 1.93 | 0.78 | Upgrade |
Free Cash Flow Per Share | 0.13 | 0.14 | 0.05 | 0.07 | 0.03 | Upgrade |
Dividend Per Share | 0.007 | 0.007 | 0.005 | - | - | Upgrade |
Dividend Growth | - | 50.00% | - | - | - | Upgrade |
Gross Margin | 69.36% | 69.93% | 66.44% | 64.78% | 60.48% | Upgrade |
Operating Margin | 9.78% | 8.08% | 5.53% | 0.64% | -30.23% | Upgrade |
Profit Margin | 5.70% | 3.59% | 1.14% | 1.42% | -23.36% | Upgrade |
Free Cash Flow Margin | 26.53% | 26.92% | 9.82% | 14.62% | 9.37% | Upgrade |
EBITDA | 1.9 | 1.66 | 1.44 | 0.93 | -1.66 | Upgrade |
EBITDA Margin | 12.62% | 11.16% | 10.22% | 7.02% | -19.87% | Upgrade |
D&A For EBITDA | 0.43 | 0.46 | 0.66 | 0.84 | 0.87 | Upgrade |
EBIT | 1.47 | 1.21 | 0.78 | 0.09 | -2.53 | Upgrade |
EBIT Margin | 9.78% | 8.08% | 5.53% | 0.64% | -30.23% | Upgrade |
Effective Tax Rate | 7.75% | 31.76% | 64.38% | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.